Open main menu

Pages with the most revisions

Showing below up to 250 results in range #21 to #270.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  2. Equivalent dose‏‎ (11 revisions)
  3. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  4. Absorbed dose‏‎ (9 revisions)
  5. Objectives of Radiological Protection‏‎ (9 revisions)
  6. Air-kerma rate constant‏‎ (9 revisions)
  7. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  8. Prudence‏‎ (8 revisions)
  9. Effects of Exposure‏‎ (8 revisions)
  10. Organ/tissue absorbed dose‏‎ (8 revisions)
  11. Beneficence‏‎ (8 revisions)
  12. Collective effective dose‏‎ (7 revisions)
  13. Linear energy transfer‏‎ (6 revisions)
  14. Accelerated fractionation‏‎ (6 revisions)
  15. Investigation level‏‎ (6 revisions)
  16. ICRPædia Guides‏‎ (6 revisions)
  17. Exposure Categories and Situations‏‎ (6 revisions)
  18. Justice‏‎ (6 revisions)
  19. Alimentary tract‏‎ (6 revisions)
  20. Kerma‏‎ (5 revisions)
  21. Protection quantities‏‎ (5 revisions)
  22. Types of materials‏‎ (5 revisions)
  23. Absorbed fraction‏‎ (5 revisions)
  24. Radiation weighting factor‏‎ (5 revisions)
  25. Sources of Radiation Exposure‏‎ (5 revisions)
  26. Quality factor‏‎ (5 revisions)
  27. Air-kerma, entrance surface‏‎ (5 revisions)
  28. Principle of optimisation‏‎ (5 revisions)
  29. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  30. Dose coefficient‏‎ (5 revisions)
  31. Justification‏‎ (5 revisions)
  32. Computed tomography dose index‏‎ (4 revisions)
  33. Direct bioassay‏‎ (4 revisions - redirect page)
  34. Bioassay‏‎ (4 revisions)
  35. Calculating Radon Doses‏‎ (4 revisions)
  36. Alpha decay‏‎ (4 revisions)
  37. Kp index‏‎ (4 revisions)
  38. Effective charge number‏‎ (4 revisions)
  39. Protective action‏‎ (4 revisions)
  40. Reference Animal and Plant‏‎ (4 revisions)
  41. Source-related assessment‏‎ (4 revisions)
  42. Risk‏‎ (4 revisions)
  43. Senescence‏‎ (4 revisions)
  44. Effective half-life‏‎ (4 revisions)
  45. Averted dose‏‎ (4 revisions)
  46. Reference bioassay function‏‎ (4 revisions)
  47. Optimisation‏‎ (4 revisions)
  48. Forbiddenness‏‎ (4 revisions)
  49. Aerodynamic diameter‏‎ (4 revisions)
  50. ICRP‏‎ (4 revisions)
  51. Sievert‏‎ (4 revisions)
  52. Diagnostic reference level‏‎ (4 revisions)
  53. S coefficient (radiation weighted)‏‎ (4 revisions)
  54. Non-maleficence‏‎ (4 revisions)
  55. Air-kerma, product‏‎ (4 revisions)
  56. Fractionation sensitivity‏‎ (4 revisions)
  57. Mass median diameter‏‎ (4 revisions)
  58. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  59. Math‏‎ (4 revisions)
  60. Programmed cell death‏‎ (4 revisions)
  61. High linear energy transfer radiation‏‎ (4 revisions)
  62. Target region‏‎ (3 revisions)
  63. Growth fraction‏‎ (3 revisions)
  64. Excretion rate (instantaneous)‏‎ (3 revisions)
  65. Extrathoracic airways‏‎ (3 revisions)
  66. Galactic cosmic radiation‏‎ (3 revisions)
  67. Growth hormone (somatotropin)‏‎ (3 revisions)
  68. ICRP Publication 103‏‎ (3 revisions)
  69. DNA damage signalling‏‎ (3 revisions)
  70. Potential exposure‏‎ (3 revisions)
  71. Fairness‏‎ (3 revisions)
  72. Absorption‏‎ (3 revisions)
  73. Gamma ray‏‎ (3 revisions)
  74. Cardiomyopathy‏‎ (3 revisions)
  75. Rigidity threshold‏‎ (3 revisions)
  76. Low Earth orbit‏‎ (3 revisions)
  77. Dose equivalent‏‎ (3 revisions)
  78. X ray‏‎ (3 revisions)
  79. Field-size effect (Volume effect)‏‎ (3 revisions)
  80. Gastrointestinal syndrome‏‎ (3 revisions)
  81. Biomedical research volunteer‏‎ (3 revisions)
  82. Dose limit‏‎ (3 revisions)
  83. Unsealed source‏‎ (3 revisions)
  84. Xerostomia‏‎ (3 revisions)
  85. Flexible tissues‏‎ (3 revisions)
  86. Guide to the System of Radiological Protection‏‎ (3 revisions)
  87. Autonomy‏‎ (3 revisions)
  88. Constancy test‏‎ (3 revisions)
  89. Interphase death‏‎ (3 revisions)
  90. Test‏‎ (3 revisions)
  91. Dose‏‎ (3 revisions)
  92. Dose limits‏‎ (3 revisions)
  93. Fluence‏‎ (3 revisions)
  94. Public exposure‏‎ (3 revisions)
  95. DS02‏‎ (3 revisions)
  96. Uptake‏‎ (3 revisions)
  97. Fluoroscopically guided interventions‏‎ (3 revisions)
  98. Annual dose‏‎ (3 revisions)
  99. Cell death‏‎ (3 revisions)
  100. Contamination‏‎ (3 revisions)
  101. Dose of record (E)‏‎ (3 revisions)
  102. Utilitarian ethics‏‎ (3 revisions)
  103. Operational quantity‏‎ (3 revisions)
  104. Accountability‏‎ (3 revisions)
  105. Half-life, physical‏‎ (3 revisions)
  106. Value judgement‏‎ (3 revisions)
  107. Exponential survival curve‏‎ (3 revisions)
  108. Annual limit on intake‏‎ (3 revisions)
  109. Dose per content function‏‎ (3 revisions)
  110. Valvular heart disease‏‎ (3 revisions)
  111. Equity‏‎ (3 revisions)
  112. Personal dose equivalent‏‎ (3 revisions)
  113. Principle of justification‏‎ (3 revisions)
  114. Graded approach‏‎ (3 revisions)
  115. Radiofrequency ablation‏‎ (3 revisions)
  116. Iso-effect plots‏‎ (3 revisions)
  117. Lifetime risk estimates‏‎ (3 revisions)
  118. Virtue ethics‏‎ (3 revisions)
  119. Fractionation‏‎ (3 revisions)
  120. Isomers‏‎ (3 revisions)
  121. Voxel phantom‏‎ (3 revisions)
  122. Active (red) bone marrow‏‎ (3 revisions)
  123. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  124. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  125. Coster-Kronig transition‏‎ (3 revisions)
  126. Organ dose equivalent‏‎ (3 revisions)
  127. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  128. Emergency preparedness‏‎ (3 revisions)
  129. Gray‏‎ (3 revisions)
  130. Spread-out Bragg peak‏‎ (3 revisions)
  131. Emergency procedures‏‎ (3 revisions)
  132. Absolute risk‏‎ (3 revisions)
  133. Auger transition‏‎ (3 revisions)
  134. Recovery‏‎ (3 revisions)
  135. Bystander effect‏‎ (3 revisions)
  136. Complex tissues‏‎ (3 revisions)
  137. Derived air concentration‏‎ (3 revisions)
  138. Dignity‏‎ (3 revisions)
  139. Wisdom‏‎ (3 revisions)
  140. Employer‏‎ (3 revisions)
  141. Activity median thermodynamic diameter‏‎ (3 revisions)
  142. Reversibility‏‎ (2 revisions)
  143. Clonogenic cells‏‎ (2 revisions)
  144. In vivo radiobioassay‏‎ (2 revisions)
  145. Solar particle event‏‎ (2 revisions)
  146. Curie‏‎ (2 revisions)
  147. Effect Dose 50‏‎ (2 revisions)
  148. Worker‏‎ (2 revisions)
  149. Nuclear track detectors‏‎ (2 revisions)
  150. Endogeneous excretion‏‎ (2 revisions)
  151. Exposure to Radon at Home‏‎ (2 revisions)
  152. GATA binding protein 2‏‎ (2 revisions)
  153. Radiation safety officer‏‎ (2 revisions)
  154. Radioresponsiveness‏‎ (2 revisions)
  155. Hormones‏‎ (2 revisions)
  156. Authorization‏‎ (2 revisions)
  157. Recovery responder‏‎ (2 revisions)
  158. Cardiac arrhythmias‏‎ (2 revisions)
  159. Right to know‏‎ (2 revisions)
  160. Clonogenic survival‏‎ (2 revisions)
  161. Incidence‏‎ (2 revisions)
  162. Solar wind‏‎ (2 revisions)
  163. Cytokines‏‎ (2 revisions)
  164. Target tissue‏‎ (2 revisions)
  165. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  166. Working level‏‎ (2 revisions)
  167. OLINDA/EXM‏‎ (2 revisions)
  168. Particle radiance‏‎ (2 revisions)
  169. Protection strategy‏‎ (2 revisions)
  170. Acute radiation syndrome‏‎ (2 revisions)
  171. Radiation source‏‎ (2 revisions)
  172. Radiosensitiser‏‎ (2 revisions)
  173. Hounsfield unit‏‎ (2 revisions)
  174. Authorized limit‏‎ (2 revisions)
  175. Rehabilitation of living conditions‏‎ (2 revisions)
  176. ICRP Publication 118‏‎ (2 revisions)
  177. Cardiac valve diseases‏‎ (2 revisions)
  178. Rigidity‏‎ (2 revisions)
  179. Security‏‎ (2 revisions)
  180. Incident‏‎ (2 revisions)
  181. Intermediate level waste‏‎ (2 revisions)
  182. Stenosis‏‎ (2 revisions)
  183. Local DRL‏‎ (2 revisions)
  184. Disposal‏‎ (2 revisions)
  185. Tolerability‏‎ (2 revisions)
  186. Medical exposure‏‎ (2 revisions)
  187. Dose criteria‏‎ (2 revisions)
  188. Naturally occurring radioactive material‏‎ (2 revisions)
  189. Working level month‏‎ (2 revisions)
  190. Environmental exposure‏‎ (2 revisions)
  191. Exempt waste‏‎ (2 revisions)
  192. Adaptive response‏‎ (2 revisions)
  193. Alveolar-interstitial region‏‎ (2 revisions)
  194. Radiosensitivity, cellular‏‎ (2 revisions)
  195. Autoimmune disease‏‎ (2 revisions)
  196. Co-expertise‏‎ (2 revisions)
  197. Inclusiveness‏‎ (2 revisions)
  198. Connective tissue‏‎ (2 revisions)
  199. Source-related‏‎ (2 revisions)
  200. Internal conversion electron‏‎ (2 revisions)
  201. DRL process‏‎ (2 revisions)
  202. LD 50/30‏‎ (2 revisions)
  203. Telangiectasia‏‎ (2 revisions)
  204. Member of the public‏‎ (2 revisions)
  205. Unattached fraction‏‎ (2 revisions)
  206. Necrosis‏‎ (2 revisions)
  207. Environmental radiation protection‏‎ (2 revisions)
  208. Patient entrance reference point‏‎ (2 revisions)
  209. Exemption level‏‎ (2 revisions)
  210. Potential recoverability correction factor‏‎ (2 revisions)
  211. Protective action guide‏‎ (2 revisions)
  212. Radiation worker‏‎ (2 revisions)
  213. Cardioverter-defibrillator‏‎ (2 revisions)
  214. Self-help protection‏‎ (2 revisions)
  215. Individual-related‏‎ (2 revisions)
  216. Consequential late effects‏‎ (2 revisions)
  217. Storage‏‎ (2 revisions)
  218. Track structure‏‎ (2 revisions)
  219. Mendelian diseases‏‎ (2 revisions)
  220. Neurological syndrome‏‎ (2 revisions)
  221. Effective dose equivalent‏‎ (2 revisions)
  222. Occupational exposure‏‎ (2 revisions)
  223. Peak skin dose‏‎ (2 revisions)
  224. Existing exposure situation‏‎ (2 revisions)
  225. Gastroschisis‏‎ (2 revisions)
  226. Radioactive dispersion device‏‎ (2 revisions)
  227. Angiogenesis‏‎ (2 revisions)
  228. Radon: Units of Measure‏‎ (2 revisions)
  229. Hyperbaric oxygen‏‎ (2 revisions)
  230. Reference air kerma‏‎ (2 revisions)
  231. Bioturbation‏‎ (2 revisions)
  232. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  233. Cohort study‏‎ (2 revisions)
  234. Individual decontamination‏‎ (2 revisions)
  235. DRL value‏‎ (2 revisions)
  236. Subcutaneous tissue‏‎ (2 revisions)
  237. Low dose rate‏‎ (2 revisions)
  238. Transfer compartment‏‎ (2 revisions)
  239. Mitigation‏‎ (2 revisions)
  240. Upper reference levels‏‎ (2 revisions)
  241. Neurovascular syndrome‏‎ (2 revisions)
  242. Epithelium‏‎ (2 revisions)
  243. Pelagic‏‎ (2 revisions)
  244. Practical radiological protection culture‏‎ (2 revisions)
  245. Acceptance test‏‎ (2 revisions)
  246. Gastrulation‏‎ (2 revisions)
  247. Radioactive source‏‎ (2 revisions)
  248. Habitual mouth breather‏‎ (2 revisions)
  249. Annihilation photons‏‎ (2 revisions)
  250. Hyperfractionation‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)